MEDIVATION, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 83 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-09-28: Reporting owner YARNO WENDY L; Form 4; Security Non-Qualified Stock Option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2016-09-28: Reporting owner YARNO WENDY L; Form 4; Security Non-Qualified Stock Option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2016-09-28: Reporting owner YARNO WENDY L; Form 4; Security Non-Qualified Stock Option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2016-09-28: Reporting owner YARNO WENDY L; Form 4; Security Non-Qualified Stock Option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-09-28 | YARNO WENDY L Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $26.36 exercise price | 2016-09-30 | |
| 2016-09-28 | YARNO WENDY L Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,232 0 owned after | $24.60 exercise price | 2016-09-30 | |
| 2016-09-28 | YARNO WENDY L Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,584 0 owned after | $38.89 exercise price | 2016-09-30 | |
| 2016-09-28 | YARNO WENDY L Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,284 0 owned after | $55.45 exercise price | 2016-09-30 | |
| 2016-09-28 | YARNO WENDY L Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,228 0 owned after | $58.89 exercise price | 2016-09-30 | |
| 2016-09-28 | Yang Tseli Lily Officer (VP, Finance and Accounting) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −33,388 0 owned after | $42.50 exercise price | 2016-09-30 | |
| 2016-09-28 | Yang Tseli Lily Officer (VP, Finance and Accounting) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −25,690 0 owned after | $35.77 exercise price | 2016-09-30 | |
| 2016-09-28 | VERNON W ANTHONY Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −60,000 0 owned after | $5.60 exercise price | 2016-09-30 | |
| 2016-09-28 | VERNON W ANTHONY Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −60,000 0 owned after | $2.21 exercise price | 2016-09-30 | |
| 2016-09-28 | VERNON W ANTHONY Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −60,000 0 owned after | $5.50 exercise price | 2016-09-30 | |
| 2016-09-28 | VERNON W ANTHONY Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $23.74 exercise price | 2016-09-30 | |
| 2016-09-28 | VERNON W ANTHONY Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,232 0 owned after | $24.60 exercise price | 2016-09-30 | |
| 2016-09-28 | VERNON W ANTHONY Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,584 0 owned after | $38.89 exercise price | 2016-09-30 | |
| 2016-09-28 | VERNON W ANTHONY Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,284 0 owned after | $55.45 exercise price | 2016-09-30 | |
| 2016-09-28 | VERNON W ANTHONY Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,228 0 owned after | $58.89 exercise price | 2016-09-30 | |
| 2016-09-28 | Svoronos Dawn Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $26.36 exercise price | 2016-09-30 | |
| 2016-09-28 | Svoronos Dawn Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,232 0 owned after | $24.60 exercise price | 2016-09-30 | |
| 2016-09-28 | Svoronos Dawn Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,584 0 owned after | $38.89 exercise price | 2016-09-30 | |
| 2016-09-28 | Svoronos Dawn Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,046 0 owned after | $44.82 exercise price | 2016-09-30 | |
| 2016-09-28 | Svoronos Dawn Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,284 0 owned after | $55.45 exercise price | 2016-09-30 | |
| 2016-09-28 | Svoronos Dawn Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,228 0 owned after | $58.89 exercise price | 2016-09-30 | |
| 2016-09-28 | Powell Andrew Kenneth William Officer (SVP, General Counsel & Crp Sec) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −40,860 0 owned after | $64.17 exercise price | 2016-09-30 | |
| 2016-09-28 | Powell Andrew Kenneth William Officer (SVP, General Counsel & Crp Sec) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −38,530 0 owned after | $35.77 exercise price | 2016-09-30 | |
| 2016-09-28 | McCourt Marion Officer (Chief Operating Officer) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −80,905 0 owned after | $31.58 exercise price | 2016-09-30 | |
| 2016-09-28 | Machado Patrick Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −264,000 0 owned after | $8.64 exercise price | 2016-09-30 | |
| 2016-09-28 | Machado Patrick Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −33,336 0 owned after | $3.37 exercise price | 2016-09-30 | |
| 2016-09-28 | Machado Patrick Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −90,000 0 owned after | $27.43 exercise price | 2016-09-30 | |
| 2016-09-28 | Machado Patrick Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,584 0 owned after | $38.89 exercise price | 2016-09-30 | |
| 2016-09-28 | Machado Patrick Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,284 0 owned after | $55.45 exercise price | 2016-09-30 | |
| 2016-09-28 | Machado Patrick Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,228 0 owned after | $58.89 exercise price | 2016-09-30 | |
| 2016-09-28 | King Michael L Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,235 0 owned after | $42.77 exercise price | 2016-09-30 | |
| 2016-09-28 | King Michael L Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,228 0 owned after | $58.89 exercise price | 2016-09-30 | |
| 2016-09-28 | Jarrett Jennifer Officer (Chief Financial Officer) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −119,885 0 owned after | $46.45 exercise price | 2016-09-30 | |
| 2016-09-28 | Hung David Director, Officer (President and CEO) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −448,888 0 owned after | $5.29 exercise price | 2016-09-30 | |
| 2016-09-28 | Hung David Director, Officer (President and CEO) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −366,194 0 owned after | $4.69 exercise price | 2016-09-30 | |
| 2016-09-28 | Hung David Director, Officer (President and CEO) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −593,750 0 owned after | $8.64 exercise price | 2016-09-30 | |
| 2016-09-28 | Hung David Director, Officer (President and CEO) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −400,000 0 owned after | $3.37 exercise price | 2016-09-30 | |
| 2016-09-28 | Hung David Director, Officer (President and CEO) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −310,000 0 owned after | $27.43 exercise price | 2016-09-30 | |
| 2016-09-28 | Hung David Director, Officer (President and CEO) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −266,000 0 owned after | $41.78 exercise price | 2016-09-30 | |
| 2016-09-28 | Hung David Director, Officer (President and CEO) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −228,000 0 owned after | $52.67 exercise price | 2016-09-30 | |
| 2016-09-28 | Hung David Director, Officer (President and CEO) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −205,500 0 owned after | $35.77 exercise price | 2016-09-30 | |
| 2016-09-28 | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −24,000 0 owned after | $8.64 exercise price | 2016-09-30 | |
| 2016-09-28 | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −60,000 0 owned after | $3.79 exercise price | 2016-09-30 | |
| 2016-09-28 | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,880 0 owned after | $27.43 exercise price | 2016-09-30 | |
| 2016-09-28 | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,740 0 owned after | $35.96 exercise price | 2016-09-30 | |
| 2016-09-28 | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,460 0 owned after | $52.85 exercise price | 2016-09-30 | |
| 2016-09-28 | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −13,560 0 owned after | $60.53 exercise price | 2016-09-30 | |
| 2016-09-28 | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,380 0 owned after | $42.50 exercise price | 2016-09-30 | |
| 2016-09-28 | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −38,530 0 owned after | $35.77 exercise price | 2016-09-30 | |
| 2016-09-28 | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,120 0 owned after | $46.45 exercise price | 2016-09-30 | |
| 2016-09-28 | FALBERG KATHRYN E Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $27.18 exercise price | 2016-09-30 | |
| 2016-09-28 | FALBERG KATHRYN E Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,232 0 owned after | $24.60 exercise price | 2016-09-30 | |
| 2016-09-28 | FALBERG KATHRYN E Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,584 0 owned after | $38.89 exercise price | 2016-09-30 | |
| 2016-09-28 | FALBERG KATHRYN E Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,284 0 owned after | $55.45 exercise price | 2016-09-30 | |
| 2016-09-28 | FALBERG KATHRYN E Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,228 0 owned after | $58.89 exercise price | 2016-09-30 | |
| 2016-09-28 | BLICKENSTAFF KIM D Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −34,500 0 owned after | $2.21 exercise price | 2016-09-30 | |
| 2016-09-28 | BLICKENSTAFF KIM D Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −60,000 0 owned after | $5.50 exercise price | 2016-09-30 | |
| 2016-09-28 | BLICKENSTAFF KIM D Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $23.74 exercise price | 2016-09-30 | |
| 2016-09-28 | BLICKENSTAFF KIM D Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,232 0 owned after | $24.60 exercise price | 2016-09-30 | |
| 2016-09-28 | BLICKENSTAFF KIM D Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,584 0 owned after | $38.89 exercise price | 2016-09-30 | |
| 2016-09-28 | BLICKENSTAFF KIM D Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,284 0 owned after | $55.45 exercise price | 2016-09-30 | |
| 2016-09-28 | BLICKENSTAFF KIM D Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,228 0 owned after | $58.89 exercise price | 2016-09-30 | |
| 2016-09-21 | BLICKENSTAFF KIM D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,500 34,500 owned after | $2.21 exercise price | 2016-09-26 | |
| 2016-09-15 | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,620 0 owned after | $4.00 exercise price | 2016-09-19 | |
| 2016-09-15 | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,940 0 owned after | $4.69 exercise price | 2016-09-19 | |
| 2016-09-15 | Hung David Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,446 448,888 owned after | $5.29 exercise price | 2016-09-19 | |
| 2016-09-15 | Hung David Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −21,308 366,194 owned after | $4.69 exercise price | 2016-09-19 | |
| 2016-06-22 | YARNO WENDY L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,228 6,228 owned after | $58.89 exercise price | 2016-06-23 | |
| 2016-06-22 | VERNON W ANTHONY Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,228 6,228 owned after | $58.89 exercise price | 2016-06-23 | |
| 2016-06-22 | Svoronos Dawn Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,228 6,228 owned after | $58.89 exercise price | 2016-06-23 | |
| 2016-06-22 | Machado Clarence Patrick Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,228 6,228 owned after | $58.89 exercise price | 2016-06-23 | |
| 2016-06-22 | King Michael L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,228 6,228 owned after | $58.89 exercise price | 2016-06-23 | |
| 2016-06-22 | FALBERG KATHRYN E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,228 6,228 owned after | $58.89 exercise price | 2016-06-23 | |
| 2016-06-22 | BLICKENSTAFF KIM D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,228 6,228 owned after | $58.89 exercise price | 2016-06-23 | |
| 2016-04-08 | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,120 1,120 owned after | $46.45 exercise price | 2016-04-08 | |
| 2016-04-08 | Jarrett Jennifer Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +119,885 119,885 owned after | $46.45 exercise price | 2016-04-08 | |
| 2016-02-29 | Yang Tseli Lily Officer (VP, Finance and Accounting) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,690 25,690 owned after | $35.77 exercise price | 2016-03-02 | |
| 2016-02-29 | Powell Andrew Kenneth William Officer (SVP, General Counsel & Crp Sec) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +38,530 38,530 owned after | $35.77 exercise price | 2016-03-02 | |
| 2016-02-29 | Hung David Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +205,500 205,500 owned after | $35.77 exercise price | 2016-03-02 | |
| 2016-02-29 | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +38,530 38,530 owned after | $35.77 exercise price | 2016-03-02 | |
| 2016-02-29 | Bierly Rick Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +51,380 51,380 owned after | $35.77 exercise price | 2016-03-02 | |
| 2016-02-16 | McCourt Marion Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +80,905 80,905 owned after | $31.58 exercise price | 2016-02-17 | |
| 2016-01-19 | Machado Clarence Patrick Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −75,000 33,336 owned after | $3.37 exercise price | 2016-01-21 |